Timothy Barabe

Timothy C.
Barabe is currently an Independent Director at HeartFlow, Inc. since 2022, a Director at Vigilant Biosciences, Inc. since 2014, and an Independent Director at Cartesian Therapeutics, Inc. since 2016.
Former roles include Finance Director at Ciba-Geigy Corp., Director at Autonomous Technologies Corp.
from 1994 to 1999, Director at ArQule, Inc. from 2001 to 2020, Independent Director at Veeva Systems, Inc. from 2015 to 2021, Independent Director at Selecta Biosciences, Inc., Managing Director-United Kingdom at Mölnlycke Health Care Group AB in 2006, Independent Director at Opexa Therapeutics, Inc. from 2014 to 2017, Director at BioCure, Inc. from 1998 to 2003, Director at Project Open Hand, Inc. from 2014 to 2020, Chief Financial Officer & Senior Vice President at Human Genome Sciences, Inc. from 2006 to 2010, Chief Financial Officer, Treasurer & Executive VP at Affymetrix, Inc. from 2012 to 2013, President-Specialty Lens Business Franchise at Ciba Vision Corp.
from 1993 to 2003, Chief Financial Officer at Sandoz International GmbH, Chief Financial Officer at Regent Medical Ltd. from 2004 to 2006, Chief Financial Officer at Sandoz GmbH from 1982 to 2004, and Treasurer & Trustee at Fernbank Museum of Natural History from 1997 to 2003.
Education includes an MBA from The University of Chicago and undergraduate studies at the University of Massachusetts.